In this Insights series, Around the World in HTAs, we shed light on HTA around the world. In this edition, Andrés ...

Pharmacogenomics (PGx) is the study of how genetic variation affects the efficacy and safety of medicines, enabling ...

Analysis of Trump’s ‘Most Favoured Nation’ Executive Order on drug pricing, its global impact, price convergence aims, and ...

New OHE insight on immunisation: despite high returns on investment, global spending lags. We outline why and how countries ...

Kiran Bhatti joined OHE in March 2025 as a Business Executive. She holds an MBA Master of Business Administration degree. She is a finance professional with over 18 years’ experience in business ...

Neil McAuslane PhD, MSc, BSc. Scientific Director of the Centre for Innovation in Regulatory Science (CIRS) overseeing the scientific content of both CIRS regulatory and HTA programmes. Key research ...

To help inform the current debate on assisted dying, we have updated the findings of our 2019 palliative report with the latest data. A previous OHE report in 2019 estimated that 378, 427 people in ...

Our literature review suggests that there are more than 100 inequalities impacting on people living with dementia and their carers across multiple characteristics, circumstances, and in various parts ...

In our Around the World in HTAs insight series we shed light on HTA successes and challenges around the world. In this edition, Sarin KC, Manit Sittimart, Chittawan Poonsiri, Yi Wang, and Simon ...